NCT03372733View on ClinicalTrials.gov

Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults

PHASE2RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Cardiovascular Disease
Interventions
DRUG

control olive oil (COO)

2 capsules, 2 times a day after meals in a total of 4 capsules a day

DRUG

palmitoleate-rich oil (PLO)

2 capsules, 2 times a day after meals in a total of 4 capsules a day

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH